Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
Journal of Cardiovascular Development and Disease
|
October 28, 2025
Trends in Conventional Heart Failure Therapy in a Real-World Multinational ATTR-CA Cohort
Eva H van der Geest, Nina Ajmone Marsan, Dorien Laenens, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
December 2, 2020
Telehealth Opportunities in the COVID-19 Pandemic Early Days: What Happened, Did Not Happen, Should Have Happened, and Must Happen in the Near Future?
Paula Amorim, Dulce Brito, Miguel Castelo-Branco, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
September 2, 2024
Right Ventricular to Pulmonary Artery Coupling and Prognosis in Transthyretin Cardiac Amyloidosis
Maria Chiara Meucci, Dorien Laenens, Rosa Lillo, et al.
Biomedicines
|
October 29, 2025
Fabry Disease Screening in Patients with Idiopathic HCM or LVH: Data from the Multicentric Nationwide F-CHECK Study
Raquel Machado, Inês Fortuna, Sílvia Sousa, et al.
ESC Heart Failure
|
February 19, 2026
Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
Dorien Laenens, Philippe Debonnaire, Maarten A J De Smet, et al.
Global Heart
|
October 30, 2023
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Dulce Brito, Fabiano Castro Albrecht, Diego Perez de Arenaza, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
February 9, 2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
Luis R Lopes, Maria-Angela Losi, Nabeel Sheikh, et al.
Intensive Care Medicine
|
January 27, 2025
Role of major cardiovascular surgery-induced metabolic reprogramming in acute kidney injury in critical care
Tiago R Velho, Francisco Pinto, Ricardo Ferreira, et al.
ESC Heart Failure
|
June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
JAMA Cardiology
|
September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial
Jean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
Journal of Cardiovascular Development and Disease
|
October 28, 2025
Trends in Conventional Heart Failure Therapy in a Real-World Multinational ATTR-CA Cohort
Eva H van der Geest, Nina Ajmone Marsan, Dorien Laenens, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
December 2, 2020
Telehealth Opportunities in the COVID-19 Pandemic Early Days: What Happened, Did Not Happen, Should Have Happened, and Must Happen in the Near Future?
Paula Amorim, Dulce Brito, Miguel Castelo-Branco, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
September 2, 2024
Right Ventricular to Pulmonary Artery Coupling and Prognosis in Transthyretin Cardiac Amyloidosis
Maria Chiara Meucci, Dorien Laenens, Rosa Lillo, et al.
Biomedicines
|
October 29, 2025
Fabry Disease Screening in Patients with Idiopathic HCM or LVH: Data from the Multicentric Nationwide F-CHECK Study
Raquel Machado, Inês Fortuna, Sílvia Sousa, et al.
ESC Heart Failure
|
February 19, 2026
Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
Dorien Laenens, Philippe Debonnaire, Maarten A J De Smet, et al.
Global Heart
|
October 30, 2023
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Dulce Brito, Fabiano Castro Albrecht, Diego Perez de Arenaza, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
February 9, 2022
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
Luis R Lopes, Maria-Angela Losi, Nabeel Sheikh, et al.
Intensive Care Medicine
|
January 27, 2025
Role of major cardiovascular surgery-induced metabolic reprogramming in acute kidney injury in critical care
Tiago R Velho, Francisco Pinto, Ricardo Ferreira, et al.
ESC Heart Failure
|
June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.
JAMA Cardiology
|
September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial
Jean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.
Page
of 13